| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/01/2003 | US20030082153 Stem cells that transform to beating cardiomyocytes |
| 05/01/2003 | US20030082152 Animal growth regulators; controlling cell differentiation; tissue engineering |
| 05/01/2003 | US20030082150 Recombinant adenoviral vectors for human tumour gene therapy |
| 05/01/2003 | US20030082142 Replication incompetent herpes viruses for use in gene therapy |
| 05/01/2003 | US20030082140 Increasing the amount of the cell differentiation associated protein, MDA-7 and decreasing RAS gene activity by administering a viral vector comprising an MDA-7 gene and an antisense ras oligonucleotide; treating pancreatic cancer |
| 05/01/2003 | US20030082139 Genetically modified human embryonic cells using a viral vector encoding an oncogene, can express active cytokines, chemokines, and other cytotoxic and neurotoxic substances; used for screening of compounds for diseases |
| 05/01/2003 | CA2464606A1 Method of modulating the immunoactivity of an immunocompetent graft by progenipoietin |
| 05/01/2003 | CA2464417A1 Promoters to control cell differentiation |
| 05/01/2003 | CA2464394A1 Methods and compositions for inducing tumor-specific cytotoxicity |
| 05/01/2003 | CA2464349A1 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 05/01/2003 | CA2464088A1 Stem cells that transform to beating cardiomyocytes |
| 05/01/2003 | CA2463960A1 Transient immortalization |
| 05/01/2003 | CA2429505A1 Prevention of recurrent viral disease |
| 04/30/2003 | CN1414846A Topical anti-microbial compositions |
| 04/30/2003 | CN1413722A Chinese patent drug for treating thrombus obliterating angiitis |
| 04/30/2003 | CN1413718A Chinese medicinal powder for treating headache |
| 04/30/2003 | CN1413717A Chinese medicineal powder for treating alopecia areata, male pattern alopecia and juvenile hoary hair |
| 04/30/2003 | CN1413709A Traditional Chinese medicine of grinding, mixing and drying for added with other Chinese patent drug |
| 04/30/2003 | CN1413704A Huafeng pill |
| 04/30/2003 | CN1413702A 金乌骨通胶囊及其制备工艺 Ukrainian bone Capsule and its preparation process |
| 04/30/2003 | CN1413684A Medicine for treating stomach disease |
| 04/30/2003 | CN1413674A Health-care liquid, powder for antitumor and prevention and curing |
| 04/30/2003 | CN1413667A Health-care food with fatigue resistance, regulating immunologic function and its preparation method |
| 04/30/2003 | CN1413662A Decoction for positive reaction of hepatitis B transformation to negative |
| 04/30/2003 | CN1413654A Chinese medicine pill for treating cough |
| 04/30/2003 | CN1413645A Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof |
| 04/30/2003 | CN1413640A Chinese medicine composition for treating enteritis |
| 04/30/2003 | CN1413638A Chinese medicine composite for treating gouty arthropathy |
| 04/30/2003 | CN1413637A Chinese medicine composite for treating rheumatism, rheumatic arthritis |
| 04/30/2003 | CN1413631A Medicine for treating stomach disease |
| 04/30/2003 | CN1413620A Shugan Zhitong soft extract for treating hepatitis |
| 04/30/2003 | CN1413618A Sanweishenxue capsule for treating aplastic anemia and its preparation technology |
| 04/30/2003 | CN1413615A Tongmailing pill and its preparation method |
| 04/30/2003 | CN1413614A Yubi pill-for treatment of rheumatism and atrophic arthritis and its preparation method |
| 04/30/2003 | CN1413599A Capsule for removing obstruction inchannels to removing blood stasis and its making method |
| 04/30/2003 | CN1413598A Manufacture technology of nano bee glue |
| 04/30/2003 | CN1413597A Method for treatment of injury and rhinitis bleeding |
| 04/30/2003 | CN1413596A Yoghurt containing ossein protein capsule, chewing tablet and its preparation method |
| 04/30/2003 | CN1413578A Preparation method of sheep embryo nutrient freeze-drying powder |
| 04/30/2003 | CN1107228C Method for producing blood separating agent |
| 04/30/2003 | CN1106856C Medicine for treating hepatosis and its preparation method |
| 04/30/2003 | CN1106855C Oral liquid for treating digestive system tumor |
| 04/30/2003 | CN1106854C Ointment for treating burn and scald and its preparation process |
| 04/30/2003 | CN1106853C Capsule for treating epilepsy |
| 04/30/2003 | CN1106852C Medicine for treating cough and its preparation process |
| 04/30/2003 | CN1106851C 三七胶囊 Thirty-seven Capsules |
| 04/30/2003 | CN1106850C Medical capsule for reinforcing vital energy of kidney and making body stronger |
| 04/30/2003 | CN1106849C Hypoglycemic capsules |
| 04/30/2003 | CN1106848C Medicine for treating lumbar vertebrae disease and its preparation process |
| 04/30/2003 | CN1106847C Medicated wine for curing rheumatism and rheumatoid disease and its preparing method |
| 04/30/2003 | CN1106838C Production process of bio-active forest frog's oviduct soft capsule |
| 04/29/2003 | US6555377 Process for production of mammalian cell lines |
| 04/29/2003 | US6555374 Mixture of isolated extramedullary adipose tissue-derived stromal cell and a non-adipose derived cell capable of forming a blood cell |
| 04/29/2003 | US6555345 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 04/29/2003 | US6555331 Bacteriophage assay |
| 04/29/2003 | US6555318 Method for identification of cell growth or differentiation factors |
| 04/29/2003 | US6555134 Synergistic mixtures of garlic and lycopene for preventing LDL oxidation |
| 04/29/2003 | US6555116 Hypo-allergenic pollen protein that has been treated with thioredoxin, nicotinamide adenine dinucleotide phosphate-thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH). |
| 04/29/2003 | US6555109 Non-toxic fraction isolated from the venom of Vipera xanthina |
| 04/29/2003 | CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 04/29/2003 | CA2152898C Recombinant lactic acid bacterium containing an inserted promoter and method of constructing same |
| 04/29/2003 | CA2103571C Method of treating pulmonary inflammation |
| 04/29/2003 | CA2098105C Oligoside derived from an antigen polyoside obtained from a pathogen |
| 04/29/2003 | CA2071567C Blood product, a method of producing the same and a method of determining the virus inactivation capacity of an inactivation treatment |
| 04/25/2003 | CA2409338A1 Method for protein-preserving purification of contaminated biological liquids |
| 04/24/2003 | WO2003033697A1 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 04/24/2003 | WO2003033692A2 Use of the adenoviral e2 late promoter |
| 04/24/2003 | WO2003033686A2 Keratinocytes which may be used as biologically active substances for the treatment of wounds |
| 04/24/2003 | WO2003033685A2 Method of producing human beta cell lines |
| 04/24/2003 | WO2003033681A2 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 04/24/2003 | WO2003033046A2 Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter |
| 04/24/2003 | WO2003033029A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 04/24/2003 | WO2003033015A1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 04/24/2003 | WO2003032950A1 Pharmaceutical formulation comprising (r) -bicalutamide |
| 04/24/2003 | WO2003032948A2 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| 04/24/2003 | WO2003032923A2 Induction of beta cell differentiation in human cells |
| 04/24/2003 | WO2003032735A1 Remodeling of tissues and organs |
| 04/24/2003 | WO2003014313A3 Alternative compositions and methods for the culture of stem cells |
| 04/24/2003 | WO2003005964A3 Recombinant vsv for the treatment of tumor cells |
| 04/24/2003 | WO2002088180A3 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 04/24/2003 | WO2002077204A3 Stem cell differentiation |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | WO2002056900A3 Use of slpi for treating chronic inflammatory intestinal diseases |
| 04/24/2003 | WO2002051988A3 Thymic epithelial progenitor cells and uses thereof |
| 04/24/2003 | WO2002045431A3 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 04/24/2003 | WO2002018585A8 Packaging of positive-strand rna virus replicon particles |
| 04/24/2003 | WO2002012447A3 Isolation and use of solid tumor stem cells |
| 04/24/2003 | US20030078532 Composite dressings for the treatment of wounds |
| 04/24/2003 | US20030078376 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 04/24/2003 | US20030077826 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC) |
| 04/24/2003 | US20030077825 Structures useful for bone engineering and methods |
| 04/24/2003 | US20030077823 Hair follicle stem cells for use in the treatment of nervous system disorders and cell therapy |
| 04/24/2003 | US20030077821 Methods to engineer stratified cartilage tissue |
| 04/24/2003 | US20030077819 Oncolytic virus therapy |
| 04/24/2003 | US20030077814 Lactic acid bacteria for use as tool in dentistry |
| 04/24/2003 | US20030077798 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's, diabetes and inflammation |
| 04/24/2003 | US20030077708 Antigen presenting system and methods for activation of T-cells |
| 04/24/2003 | US20030077706 Mouse cytokine receptor |
| 04/24/2003 | US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection |
| 04/24/2003 | US20030077564 Amplification of neural cell viability in brain or spinal cord tissue after brain or spinal cord injury; obtain tissue, apply nutrient broth, monitor cell viability |